Aug 12, 2026 08:05AM
Aug 12, 2026 08:05AM
Jul 9, 2026 08:06AM
Jul 9, 2026 08:05AM
Jun 18, 2026 08:05AM
Jun 18, 2026 08:05AM
Jun 9, 2026 08:05AM SCIENTURE adds REZENOPY nasal spray to major health plan formulary
Jun 9, 2026 08:05AM
Jun 2, 2026 08:06AM
Jun 2, 2026 08:05AM
May 18, 2026 08:39AM
May 18, 2026 08:38AM
May 7, 2026 08:06AM
May 7, 2026 08:05AM Scienture secures $11 million in non-dilutive debt financing
May 7, 2026 08:05AM
May 7, 2026 08:05AM
May 6, 2026 08:05AM
May 6, 2026 08:05AM
Apr 15, 2026 08:05AM
Apr 15, 2026 08:05AM
Apr 6, 2026 08:06AM Scienture reports 216% revenue increase with FDA-approved drug launch
Apr 6, 2026 08:05AM
Mar 30, 2026 08:08AM
Mar 30, 2026 08:07AM
Mar 11, 2026 08:06AM
Mar 11, 2026 08:05AM
Feb 3, 2026 08:06AM
Feb 3, 2026 08:05AM SCIENTURE Provides Commercial Update on ARBLI™, the First FDA-Approved Ready-to-Use Oral Suspension of Losartan Potassium
Jan 14, 2026 08:06AM
Jan 14, 2026 08:05AM
Dec 22, 2025 08:05AM
Dec 22, 2025 08:05AM
Dec 10, 2025 08:05AM
Dec 10, 2025 08:05AM
Nov 13, 2025 08:05AM SCIENTURE Reports Q3 2025 Financial Results and Provides Business Update
Nov 4, 2025 08:05AM
Nov 4, 2025 08:05AM
Oct 23, 2025 08:05AM
Oct 23, 2025 08:05AM
Oct 1, 2025 09:00AM
Sep 16, 2025 08:05AM
Sep 16, 2025 08:05AM SCIENTURE Secures PBM-Led GPO Rebate Agreement to Drive Expanded Commercial Coverage and Formulary Access for Arbli™(losartan potassium) in the $256M U.S. Losartan Market
Jul 16, 2025 08:15AM
Jul 16, 2025 08:15AM
Jun 17, 2025 08:05AM
Jun 17, 2025 08:05AM
May 22, 2025 08:20AM
May 22, 2025 08:05AM
Apr 3, 2025 08:26AM Scienture Holdings (SCNX) Issues Annual Letter to Shareholders
Apr 3, 2025 08:26AM

328,282 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All